Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

PHASE3CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2012

Conditions
Colorectal Cancer
Interventions
DRUG

bevacizumab

bevacizumab 7.5mg/kg every 3 weeks until disease progression or limiting toxicity

DRUG

bevacizumab, erlotinib

bevacizumab 7.5mg/kg and oral erlotinib 150 mg/day continuously Cycles every 3 weeks until disease progression or limiting toxicity

Trial Locations (47)

1090

AKH Universitätsklinik für Innere Medizin I, Vienna

4400

LKH Steyr, Steyr

4600

Klinikum Wels-Grieskirchen GmbH, Wels

8700

LKH Leoben, Leoben

13000

hôpital Ambroise Paré, Marseille

Institu Paoli Calmette, Marseille

21000

Hopital Drevon, Dijon

21140

Centre Hospitalier, Semur-en-Auxois

22000

Clinique Armoricaine, Saint-Brieuc

26000

Clinique Générale, Valence

33000

Polyclinique Bordeaux Nord, Bordeaux

33500

Hopital Robert Boulin, Libourne

40000

Centre hospitalier Layné, Mont-de-Marsan

40100

Centre Hospitalier, Dax

44000

Centre Catherine de Sienne, Nantes

54100

centre oncologie de Gentilly, Nancy

54140

Centre Hospitalier, Briey

57070

Clinique Claude BERNARD, Metz

60000

Centre Hospitalier, Beauvais

60309

C.H. Senlis, Senlis

66000

centre Catalan oncologie, Perpignan

68024

Hôpital Pasteur, Colmar

69007

Centre Hospitalier Saint Joseph Saint Luc, Lyon

69008

Hôpital Privé Jean Mermoz, Lyon

69009

Clinique de la sauvegarde, Lyon

75005

Institut Curie, Paris

75012

Groupe Hospitalier les Diaconnesses, Paris

75013

Hôpital Pitié Salpêtrière, Paris

75014

Hôpital Saint Joseph, Paris

Institut Mutualiste Montsouris, Paris

75571

Hopital Saint Antoine, Paris

75970

Hopital Tenon, Paris

77100

Centre Hospitalier, Meaux

85000

CHD les oudairies, La Roche-sur-Yon

87000

CHU Dupuytren, Limoges

89011

Centre Hospitalier, Auxerre

92151

Hopital Foch, Suresnes

93000

Hôpital Avicenne, Bobigny

93370

Centre Hospitalier Intercommunal Le Raincy - Montfermeil, Montfermeil

H7M 3L9

Ottawa Hospital Regional Cancer Centre, Ottawa

Cité de la Santé de Laval, Laval

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

H2L 4M1

CHUM Hôpital Notre-Dame, Montreal

H2W 1S6

Mc Gill University Hospital, Montreal

J4V 2H1

Hôpital Charles LeMoyne, Montreal

06606

Centre Hospitalier, Antibes

F-72000

Clinique Victor Hugo, Le Mans

All Listed Sponsors
lead

GERCOR - Multidisciplinary Oncology Cooperative Group

OTHER

NCT00265824 - Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) | Biotech Hunter | Biotech Hunter